References
1
Bellomo R, Ronco C. Continuous haemofiltration in the intensive care unit. Crit Care. 2000;4:339-45.
2
Brush KA, Bilodeau ML. Continuous renal replacement therapy. Int Anesthesiol Clin. 2001;39:111-25.
3
Abdeen O, Mehta RL. Dialysis modalities in the intensive care unit. Crit Care Clin. 2002;18:223-47.
4
Guérin C, Girard R, Selli JM, Ayzac L. Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units. Intensive Care Med. 2002;28:1411-8.
5
Kellum JA, Angus DC, Johnson JP, Leblanc M, Griffin M, et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med. 2002;28:29-7.
6
Goldstein SL. Overview of pediatric renal replacement therapy in acute renal failure. Artifical Organs. 2003;27:781-5.
7
D’Intini V, Ronco C, Bonello M, Bellomo R. Renal replacement therapy in acute renal failure. Best Pract Res Clin Anesth. 2004;18:145-57.
8
Bock KR. Renal replacement therapy in pediatric critical care medicine. Curr Opin Pediatr. 2005;17:368-71.
9
Goldstein SL. Continuous renal replacement therapy: mechanism of clearence, fluid removal, indications and outcomes. Curr Opin Pediatr. 2011;23:181-5.
10
Kornecki A, Tauman R, Lubetzky L, Sivan Y. Continuous renal replacement therapy for non-renal indications: experience in children. Isr Med Assoc J. 2012;4:345-8.
11
Sutherland SM, Goldstein SL, Alexander SR. The prospective pediatric continuous renal replacement therapy (ppCRRT) registry: a critical appraisal. Pediatr Nephrol. 2014;29:2069-76.
12
Canaud B, Desmeules S, Klouche K, Leray-Moragués H, Béraud JJ. Vascular access for dialysis in the intensive care unit. Best Pract Res Clin Anaesth. 2004;18:159-74.
13
MacLaren G, Butt W. Controversies in paediatric continuous renal replacement therapy. Intensive Care Med. 2009;35:596-602.
14
Khandelwal P, Sharm S, Bhardwaj S, Thergaonkar RW, Sinha A, et al. Experience with continuous renal replacement therapy. Indian J Pediatr. 2015;82:752-4.
15
Pasko DA, Mottes TA, Mueller BA. Pre dialysis of blood prime in continuous hemodialysis normalizes pH and electrolytes. Pediatr Nephrol. 2003;18:1177-83.
16
Saito D, Fujimaru T, Inoue Y, Hirayama T, Ezaki I, et al. Serial measurement of electrolyte and citrate concentrations in blood-primed continuous hemodialysis circuits during closed-circuit dialysis. Pediatr Nephrol. 2020;35:127-33.
17
Pedersen O, Jepsen SB, Toft P. Continuous renal replacement therapy for critically ill infants and children. Dan Med J 2012;59:A4385.
18
Sutherland SM, Alexander SM. Continuous renal replacement therapy in children. Pediatr Nephrol. 2012;27:2007-16.
19
McBryde KD, Kershaw DB, Bunchman TE, Maxvold NJ, Mottes TA, et al. Renal replacement therapy in the treatment of confirmed or suspected inborn errors of metabolism. J Pediatr. 2006;148:770-8.
20
Demirkol D, Aktuğlu ZÇ, Karacabey BN, Cesur Y, Ataman Y, et al. The role of supportive treatment in the management of hyperammonemia in neonates and infants. Blood Purif. 2019;48:150-7.
21
Eminoğlu TF, Öncül Ü, Kahveci F, Okulu E, Kraja E, et al. Characteristics of continuous venovenous hemodiafiltration in the acute treatment of inherited metabolic disorders. Pediatr Nephrol. 2022;37:1387-97.
22
Aygün F, Kıykım E, Aktuğlu-Zeybek Ç, Zubarioğlu T, Cam H. Treatment of maple syrup urine disease with high-flow hemodialysis in a neonate. Turk J Pediatr. 2019;61:107-10.
23
Santiago MJ, López-Herce J, Urbano J, Solana MJ, del Castillo J, et al. Complications of continuous renal replacement therapy in critically ill children: a prospective observational evaluation study. Crit Care. 2009;13:R184.
24
Palmieri TL. Complications of continuous renal replacement therapy in children: are all created equal. Crit Care. 2010;14:105.
25
Askenazi DJ, Goldstein SL, Koralkar R, Frontberry J, Baum M, et al. Continuous renal replacement therapy for children ≤10 kg: a report from the prospective pediatric continuous renal replacement registry. J Pediatr. 2013;162:587-92.e3.
26
Gün E, Gurbanov A, Nakip ÖS, Yöntem A, Aslan AD, et al. Clinical characteristics, and outcomes of continuous renal replacement therapy performed on young children weighing up to 10 kg. Turk J Med Sci. 2023;53:791-802.
27
Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Continuous is not continuous: the incidence and impact of circuit “down-time” on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med. 2003;29:575-8.
28
Duyu M, Turkozkan C. Clinical features and risk factors associated with mortality in critically ill children requiring continuous renal replacement therapy. Ther Apher Dial. 2022;21:1121-30.
29
Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, et al. Effects of different doses in continuous veno-venous haemofilration on outcomes of acute renal failure: a prospective randomized trial. Lancet. 2000;355:26-30.
30
Servillo G, Vagas M, Pastore A, Procino A, Iannuzzi M, et al. Immunomodulatory effect of continuous venovenous hemofiltration during sepsis: preliminary data. Biomed Res Int. 2013;2013:108951.
31
Symons JM, Chua AN, Somers MJG, Baum MA, Bunchman TE, et al. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol. 2007;2:732-8.
32
Hayes LW, Oster RA, Tofil NM, Tolwani AJ. Outcomes of critically ill children requiring continuous renal replacement therapy. J Crit Care. 2009;24:394-400.
33
Santiago MJ, López-Herce J, Urbano J, Solana MJ, del Castillo J, et al. Clinical course and mortality risk factors in critically ill children requiring continuous renal replacement therapy. Intensive Care Med. 2010;36:843-9.
34
Goonasekera CD, Wang J, Bunchman TE, Deep A. Factor affecting renal replacement therapy in children with liver failure. Ther Apher Dial. 2015;19:16-22.
35
Tandukar S, Palevsky PM. Continuous renal replacement therapy. Who, when why and how. Chest. 2019;155:626-38.
36
Daverio M, Cortina G, Jones A, Ricci Z, Demirkol D, et al. Continuous Kidney Replacement Therapy Practices in Pediatric Intensive Care Units Across Europe. JAMA Netw Open. 2022;5:e2246901.
37
Tsujimoto Y, Fujii T. How to Prolong Filter Life During Continuous Renal Replacement Therapy? Crit Care. 2022;26:62-8.
38
Baldwin I, Jones D, Carty P, Fealy N. Continuous renal replacement therapy without anticoagulation: top ten tips to prevent clotting. Blood Purif. 2020;49:490-5.
39
Szamosfalvi B, Puri V, Sohaney R, Wagner B, Riddle A, et al. Regional citrate anticoagulation protocol for patients with presumed absent citrate metabolism. Kidney360. 2021;2:192-204.
40
Zhang W, Bai M, Yu Y, Li L, Zhao L, et al. Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis. Crit Care. 2019;23:22.
41
Raymakers-Janssen PAMA, Lilian M, van Kessel IA, Veldohen ES, Wösten-van Asparen RM, et al. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children. Pediatr Nephrol. 2017;32:1971-8.
42
Rico MP, Sarmiento JF, Velasquez AMR, Chapamo LSG, Amaya RG, et al. Regional citrate anticoagulation for continuous renal replacement therapy in children. Pediatr Nephrol. 2017;32:703-11.
43
Deep A, Zoha M, Kukrega PD. Prostacyclin as an anticoagulant for continuous renal replacement therapy in children. Blood Purif. 2017;43:279-89.
44
Baeg SI, Lee K, Jeon J, Jang HR. Management for electrolytes disturbances during continuous renal replacement therapy. Electrolyte Blood Press. 2022;20:64-75.
45
Thompson Bastin ML, Adams PM, Nerusu S, Morris PE, Mayer KP, et al. Association of phosphate containing solutions with incident hypophosphatemia in critically ill patients requiring continuous renal replacement therapy. Blood Purif. 2022;51:122-9.
46
Goldstein S, Vidal E, Ricci Z, Paglialonga F, Peruzzi L, et al. Survival of infants treated with CKRT: comparing adapted adult platforms with the Carpediem™. Pediatr Nephrol. 2022;37:667-75.
47
Ostermann M, Lumlertgul N, Mehta R. Nutritional assessment and support during continuous renal replacement therapy. Semin Dial. 2021;34:449-56.
48
Mehta NM, Skillman HE, Irving SY, Coss-Bu JA, Vermilyea S, et al. Guidelines for the provision and assessment of nutrition support therapy in pediatric critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr. 2017;41:706-42.
49
Fah M, Althuis LE, Ohnuma T, Winthrop HM, Haines KL, et al. Micronutrient deficiencies in critically ill patients receiving continuous renal replacement therapy. Clin Nutr ESPEN. 2022;50:247-54.
50
Brogan TV, Lequier L, Lorusso R, MacLaren G, Peek G. Extracorporeal life support: the ELSO red book. Extra-corporeal Life Support Organization; 2017:697-701.
51
Fleming GM, Askenazi DJ, Bridges BC, Cooper DS, Paden ML, et al. A multicenter international survey of renal supportive therapy during ECMO: the Kidney Intervention During Extracorporeal Membrane Oxygenation (KIDMO) group. ASAIO J. 2012;58:407-14.
52
Mulder M, Hassan I, Lancé M. ECMO and anticoagulation: A comprehensive review. Neth J Crit Care. 2018;26:6-13.
53
Vuylsteke A, Brodie D, Combes A, Fowles JA, Peek G. Coagulation, Blood and ECMO. ECMO in the Adult Patient. Cambridge: Cambridge UP; 2017:119-140.
54
Ryerson LM, McMichael ABV. Bivalirudin in pediatric extracorporeal membrane oxygenation. Curr Opin Pediatr. 2022;34:255-60.
55
Gautam SC, Lim J, Jaar BG. Complications associated with continuous RRT. Kidney360. 2022;12:1980-90.
56
Kovvuru K, Velez JCQ. Complications associated with continuous renal replacement therapy. Semin Dial. 2021;34:489-94.
57
Demirkol D. Continuous renal replacement therapy in critically ill children. Turk Arch Pediatr. 2022;57:489-97.
58
Garzotto F, Zanella M, Ronco C. The evolution of pediatric continuous renal replacement therapy. Nephron Clin Pract. 2014;127:172-5.
59
Kara OD, Dincel N, Bulut IK, Yilmaz E, Ozdemir K, et al. Success of continuous veno-venous hemodiafiltration treatment in children monitored in the intensive care units. Ren Fail. 2014;36:1411-5.
